|1.||Hasegawa, Toshiaki: 6 articles (01/2011 - 01/2007)|
|2.||Ando, Masayoshi: 6 articles (01/2011 - 01/2007)|
|3.||Kataoka, Takao: 5 articles (01/2011 - 01/2007)|
|4.||Weiss, Johanna: 4 articles (11/2015 - 04/2011)|
|5.||Prausnitz, Mark R: 4 articles (03/2014 - 07/2002)|
|6.||Zhao, Ming: 4 articles (04/2012 - 01/2007)|
|7.||Ogura, Hirotsugu: 4 articles (01/2011 - 01/2007)|
|8.||Bai, Liming: 4 articles (01/2011 - 01/2007)|
|9.||Prausnitz, M R: 4 articles (06/2010 - 02/2001)|
|10.||Tomida, Akihiro: 4 articles (01/2008 - 02/2007)|
11/01/2011 - "However, when reperfusion was performed after 25 min simulated ischemia, CyD ablation improved ΔΨm recovery and reduced calcein release and cell death (57.8 ± 4.9% vs. 77.3 ± 4.8%, P < 0.01). "
10/01/2013 - "Ischemia also induced quenching and dequenching of calcein loaded into mitochondria and lysosomes, respectively. "
10/01/2013 - "Ischemia caused progressive quenching of cytosolic calcein by more than 90%, signifying increased chelatable Fe(2+). "
11/01/2011 - "Reperfusion after 15 min simulated ischemia induced a rapid recovery of ΔΨm, extreme cell shortening (contracture) and mitochondrial calcein release, and CyD ablation did not affect these changes or cell death. "
11/01/2011 - "Mitochondrial membrane potential (ΔΨm, JC-1) and MPT (calcein) were studied in cardiomyocytes from wild-type and cyclophilin D (CyD) KO mice refractory to MPT, submitted to simulated ischemia and 10 min reperfusion. "
01/01/2015 - "In this study, we show that the calcein release assay varies in its dynamic range for different tumor targets, and that the entrapped calcein could remain unreleased within apoptotic bodies of lysed tumor targets or incompletely released resulting in underestimation of percent specific lysis. "
01/01/2015 - "Using tumor lines K562, 721.221, and Jurkat, we demonstrate here that image cytometry shows significantly higher percent specific lysis of the target cells compared to the standard calcein release assay within the same experimental setup. "
01/01/2015 - "Activity of MDR1 and MRP1 of viable epithelial and cancer cells were determined separately with the modified calcein-assay for multidrug resistance activity and sufficient data of 73 cancer and 11 healthy mucosa was analyzed statistically. "
08/15/2010 - "The spectrophotometer fluorometry analysis and the flow cytometry analysis indicated that in comparison with CL, PLs with positive zeta potential facilitates the uptake of calcein by MCF-7 tumor cells. "
07/01/2009 - "After a human MDR cancer cell line (NCI/ADR-RES) was exposed to several F/T conditions, its cellular drug uptake was quantified by a fluorescent calcein assay using calcein as a model drug. "
|3.||Prostatic Neoplasms (Prostate Cancer)
11/01/2001 - "DU145 prostate cancer cells bathed in a solution of calcein were exposed to ultrasound at 24 kHz over a range of different acoustic pressures. "
06/01/2001 - "We, therefore, quantified the number of calcein molecules delivered and the loss of viability in prostate cancer cells exposed to 24-kHz US over a range of different pulse lengths (1 to 100 ms), total exposure times (0.1 to 10 s) and pressures (1.0 to 9.8 atm). "
02/01/2001 - "To address this need, uptake of calcein and viability of DU 145 prostate cancer cells were quantified using flow cytometry for more than 200 different combinations of experimental conditions. "
01/01/2010 - "Calcein-based immunofluorescence studies revealed the functional involvement of PHB in maintaining inner mitochondrial membrane permeability as an integral component of TGF-beta induced apoptosis in prostate cancer cells. "
04/01/2004 - "Optison was exposed to 500 kHz ultrasound (acoustic pressures of 0.6-3.0 MPa and energy exposures of 0.2-200 J/cm2) either with or without the presence of DU145 prostate cancer cells (10(6) cells/ml) bathed in calcein, a cell-impermeant tracer molecule. "
01/01/2002 - "A multidrug resistance pump efflux activity assay demonstrated increased calcein efflux of RBE4 endothelial cells, but not glioma cells, 2 h after irradiation and still increased 14 d after irradiation. "
04/01/2008 - "Specifically, we demonstrate successful calcein uptake and transfection of DNA plasmid encoding green fluorescent protein (GFP) into human malignant glioma cells (cell line LN443) using electrosonic microarrays with 36, 45 and 50 mum diameter nozzle orifices and operating at ultrasound frequencies between 0.91 and 0.98 MHz. "
01/01/2008 - "We treated glioma cell lines, LN-229 and SW1088, and melanoma cell lines, A375 and WM35, with two endothelin receptor type B (ETRB)-specific antagonists, A-192621 and BQ788, and quantified viable cells by the capacity of their intracellular esterases to convert non-fluorescent calcein AM into green-fluorescent calcein. "
03/01/2006 - "To investigate this possibility, the effects of L-DOPA on the expression of iron influx proteins [transferrin receptor (TfR) and divalent metal transporter 1 (DMT1)], iron efflux protein (ferroportin 1), and iron uptake in C6 glioma cells were determined in this study using Northern blot and Western blot analysis and the calcein method. "
|5.||Wounds and Injuries (Trauma)
06/01/2010 - "Those apoptotic cells initially had the highest levels of uptake of a marker compound, calcein; also had highly elevated levels of intracellular Ca(2+); and contained an estimated plasma membrane wound radius of 100-300 nm. Finally, we showed that chelation of intracellular Ca(2+) after sonication reduced apoptosis by up to 44%, thereby providing a strategy to save cells. "
08/01/2009 - "Osmotic water permeability, as measured by calcein fluorescence quenching, was AQP1-dependent in cultured keratocytes, as was keratocyte migration following a scratch wound. "
02/01/2012 - "The aim of this in vitro study was to investigate the effect of differently potent bisphosphonates on human oral keratinocytes (HOK).Three nitrogen-containing bisphosphonates (ibandronate, pamidronate, and zoledronate) and one non-nitrogen-containing bisphosphonate (clodronate) were compared concerning their potency on cell viability (calcein assay and MTT assay), migration ability (Boyden chamber migration assay and scratch wound proliferation assay), and apoptosis (TUNEL assay) of HOK.The"
|4.||Propidium (Propidium Iodide)
|8.||Proteins (Proteins, Gene)
|1.||Heterologous Transplantation (Xenotransplantation)